Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

PURPOSE: Cardiac involvement predicts poor prognosis in light chain (AL) amyloidosis, and the current prognostic classification is based on cardiac biomarkers troponin-T (cTnT) and N-terminal pro–B-type natriuretic peptide (NT-ProBNP). However, long-term outcome is dependent on the underlying plasma...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kumar, Shaji, Dispenzieri, Angela, Lacy, Martha Q., Hayman, Suzanne R., Buadi, Francis K., Colby, Colin, Laumann, Kristina, Zeldenrust, Steve R., Leung, Nelson, Dingli, David, Greipp, Philip R., Lust, John A., Russell, Stephen J., Kyle, Robert A., Rajkumar, S. Vincent, Gertz, Morie A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2012
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3675680/
https://ncbi.nlm.nih.gov/pubmed/22331953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.38.5724
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak